nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced the appointments of Andrew Stedman as
Nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced its final audited results for
A nanoparticle is a small particle that ranges between 1 to 100 nanometres in size. Undetectable by the human eye, nanoparticles can exhibit significantly different physical and chemical properties to
The potential of nanotechnology for cancer research has been tremendous for the medical field, leading to significant improvements in diagnostics and therapeutics. Nanoparticles and nanomaterials with remarkable physiochemical properties have
The nano-tech space is highly fragmented and ripe for consolidation/ synthesis both in terms of the pure technology itself and the range of applications against which nanotech is deployed, many
Based on the application, the feed and animal nutrition market are segmented into veterinarians, animal feed manufacturers, domestic, farms, and other application. Increasing the existing focus on the animal feed
nanosynth Group plc (LON:NANO), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced that the Company has conducted a
Austrian Health Minister Johannes Rauch on Monday said that, with current low infection rates, legal mandates for masks to be worn in essential shops and on public transport could be suspended. However, he
The Australian Medical Association (AMA) on Wednesday called for a return of face masks to mitigate an impending spike in Covid-19 and influenza cases. Chris Moy, Vice-President of the AMA,
Effective mask use can drastically slow the spread of COVID-19, reduce the magnitude of the pandemic peak by flattening the curve, and reduce the prevalence of severe cases, according to
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
